2003 Kern Aspen Lipid Conference: Integrative Mechanisms

描述（由申请人提供）： 本申请旨在为将于2003年8月16日至19日在科罗拉多州白杨举行的2003年克恩白杨脂质会议寻求资金。会议的主题是“脂质代谢的综合机制”。本次会议的目标是为与会者提供机会，了解脂质代谢广泛领域的最新发现，这些领域超出了任何一个单一的研究领域。脂质研究与各种方法的想法的交叉受精应该对所有人都有教育意义，并可能促进新的研究举措。因此，选出了今年会议的三位共同主席，他们都有不同的背景。Lawrence Rudel博士是董事会成员，是脂蛋白代谢和胆固醇运输方面的专家。小罗伯特·法瑞斯博士是三酰甘油和脂肪酸代谢方面的专家，并开发了许多酰基甘油代谢的动物模型。Joachim Herz博士是中枢神经系统研究的专家，他率先对正常大脑发育和功能所需的几种细胞表面受体进行了鉴定和功能评估。第四次会议将涵盖与代谢综合征相关的转录因子和遗传学，这次会议将由克里斯托弗·格拉斯博士领导。该会议的组织目的是将脂质研究不同领域的研究人员聚集在一起，旨在进一步了解涉及脂质代谢的疾病（包括动脉粥样硬化，糖尿病和肥胖症）的发病机制。虽然一些建议的主题可能会在其他专门会议上讨论，但我们不知道有一个单一的会议，其中包括各种领域的多样性，以交流脂质代谢在如此广泛的竞技场中的新进展。这次会议的及时性被视为一种优势。

DESCRIPTION (provided by applicant): This application is to seek funding for the 2003 Kern Aspen Lipid Conference, to be held in Aspen, CO, on August 16-19, 2003. The title of the conference is "Integrative Mechanisms of Lipid Metabolism". The goal of this meeting will be to provide attendees the opportunity to learn about the state-of-the-art findings across broad areas of lipid metabolism that extend beyond any one single research area. Cross fertilization of lipid research with ideas from a variety of approaches should be educational to all, and may promote new research initiatives. Accordingly, three co chairs for this year's meeting were selected, all of whom have different backgrounds. Dr. Lawrence Rudel is a member of the board of directors and is an expert in lipoprotein metabolism and cholesterol transport. Dr. Robert Farese, Jr. is an expert in triacylglycerol and fatty acid metabolism and has developed numerous animal models of acylglyceride metabolism. Dr. Joachim Herz is an expert in studies of the central nervous system, where he has pioneered identification and functional evaluation of several cell surface receptors that are required for normal brain development and function. A fourth session will cover transcription factors and genetics associated with the metabolic syndrome, and this session will be led by Dr. Christopher Glass. The conference is organized to bring together investigators in divergent fields in lipid research with the goal to foster further insights into the pathogenesis of diseases involving lipid metabolism including atherosclerosis, diabetes, and obesity. Although some of the proposed subjects may be covered at other specialized meetings, we are unaware of a single conference, which includes the diversity of the various fields assembled to exchange new advances in lipid metabolism across such a wide ranging arena. The timeliness of this meeting is viewed as a strength.